Australian reactor ramps up production of crucial isotope
The recent closure of a Canadian reactor has threatened the supply chain security for molybdenum-99, prompting the Australian Nuclear Science Technology Organization (ANSTO) in Sydney to drastically ramp up its production of the tracer beginning in 2017.
ANSTO will increase production at the Open Pool Australian Lightwater (OPAL)
Reactor from 5.55 million doses a year to more than 10 million, filling a
quarter of the global demand. While the closing of the Canadian reactor will
reduce global supply by 40 percent, the boost from the OPAL reactor should
secure the supply through 2020, according to a report published by the
Organization for Economic Co-Operation and Development (OECD).
To read more please visit http://www.healthimaging.com/topics/technology-management/australian-reactor-ramps-production-crucial-isotope
Source: Health Imaging